BIP
NWBO

Brandes Investment Partners’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Brandes Investment Partners’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-65,000
Closed -$23K – 224
2016
Q4 		$23K Buy
+65,000
New +$32.7K ﹤0.01% 174

Other funds holding NWBO

MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
WPP
Whalerock Point Partners Providence, Rhode Island $518M AUM 25.26% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Brandes Investment Partners's NWBO Position: Q1 2017 in Review

Brandes Investment Partners sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2017, closing a stake of 65,000 shares — an estimated $23K sold.

Brandes Investment Partners first reported a position in NWBO in Q4 2016 and held it in 1 quarter. The position peaked at $23K in Q4 2016. 4 funds tracked by Wall St. Rank hold NWBO as of Q1 2017.

  • Brandes Investment Partners reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2017 after selling out during the quarter.
  • Brandes Investment Partners sold 65,000 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2017, an estimated $23K.
  • Brandes Investment Partners first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2016 and held it in 1 quarter.
  • Brandes Investment Partners's Northwest Biotherapeutics, Inc. Common stock position peaked at $23K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2017.

Based on Brandes Investment Partners's 13F filing for Q1 2017, filed 10 May 2017.